|
aflibercept 40 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0905-00 · 1000 mL in 1 BOTTLE (61755-905-00) |
61755-0905-00 |
— |
On market |
View → |
|
aflibercept 114.3 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0950-00 · 1000 mL in 1 BOTTLE (61755-950-00) |
61755-0950-00 |
— |
On market |
View → |
|
aflibercept 50 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0930-00 · 1000 mL in 1 BOTTLE (61755-930-00) |
61755-0930-00 |
— |
On market |
View → |
|
Alirocumab 150 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0921-00 · 5000 mL in 1 BOTTLE (61755-921-00) |
61755-0921-00 |
— |
On market |
View → |
|
atoltivimab 100 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0963-00 · 1000 mL in 1 BOTTLE (61755-963-00) |
61755-0963-00 |
— |
On market |
View → |
|
atoltivimab 50 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0960-00 · 1000 mL in 1 BOTTLE (61755-960-00) |
61755-0960-00 |
— |
On market |
View → |
|
cemiplimab 175 mg/mL SOLUTION
Regeneron · NDC 61755-0909-00 · 5000 mL in 1 BOTTLE (61755-909-00) |
61755-0909-00 |
— |
On market |
View → |
|
cemiplimab 50 mg/mL SOLUTION
Regeneron · NDC 61755-0908-00 · 5000 mL in 1 BOTTLE (61755-908-00) |
61755-0908-00 |
— |
On market |
View → |
|
Dupilumab 150 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0940-00 · 5000 mL in 1 BOTTLE (61755-940-00) |
61755-0940-00 |
— |
On market |
View → |
|
Dupilumab 175 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0941-00 · 5000 mL in 1 BOTTLE (61755-941-00) |
61755-0941-00 |
— |
On market |
View → |
|
Evinacumab 150 mg/mL SOLUTION
Regeneron · NDC 61755-0910-00 · 5000 mL in 1 BOTTLE (61755-910-00) |
61755-0910-00 |
— |
On market |
View → |
|
Evkeeza evinacumab 150 mg/mL INJECTION, SOLUTION, CONCENTRATE
Regeneron · NDC 61755-0010-01 · J1305 · 1 VIAL, SINGLE-USE in 1 CARTON (61755-010-01) / 8 mL in 1 VIAL, SINGLE-USE |
61755-0010-01 |
— |
Discontinued |
View → |
|
Evkeeza evinacumab 150 mg/mL INJECTION, SOLUTION, CONCENTRATE
Regeneron · NDC 61755-0013-01 · J1305 · 1 VIAL, SINGLE-USE in 1 CARTON (61755-013-01) / 2.3 mL in 1 VIAL, SINGLE-USE |
61755-0013-01 |
— |
Discontinued |
View → |
|
EYLEA aflibercept 40 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0005-01 · J0178 · 1 SYRINGE, GLASS in 1 CARTON (61755-005-01) / .05 mL in 1 SYRINGE, GLASS |
61755-0005-01 |
— |
On market |
View → |
|
EYLEA aflibercept 40 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0005-01 · J0178 · 1 SYRINGE, GLASS in 1 CARTON (61755-005-01) / .05 mL in 1 SYRINGE, GLASS |
61755-0005-01 |
— |
On market |
View → |
|
EYLEA HD aflibercept 8 mg/.07mL INJECTION, SOLUTION
Regeneron · NDC 61755-0050-01 · J0177 · 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-01) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-00) |
61755-0050-01 |
— |
On market |
View → |
|
EYLEA HD aflibercept 8 mg/.07mL INJECTION, SOLUTION
Regeneron · NDC 61755-0051-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-051-01) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-051-00) |
61755-0051-01 |
— |
On market |
View → |
|
Inmazeb atoltivimab, maftivimab, and odesivimab-ebgn 241.7 mg/14.5mL; 241.7 mg/14.5mL; 241.7 mg/14.5mL INJECTION, SOLUTION
Regeneron · NDC 61755-0018-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-018-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-018-00) |
61755-0018-01 |
— |
On market |
View → |
|
Inmazeb atoltivimab, maftivimab, and odesivimab-ebgn 483.3 mg/14.5mL; 483.3 mg/14.5mL; 483.3 mg/14.5mL INJECTION, SOLUTION
Regeneron · NDC 61755-0019-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-019-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-019-00) |
61755-0019-01 |
— |
On market |
View → |
|
LIBTAYO cemiplimab-rwlc 50 mg/mL INJECTION
Regeneron · NDC 61755-0008-01 · J9119 · 1 VIAL, SINGLE-USE in 1 CARTON (61755-008-01) / 7 mL in 1 VIAL, SINGLE-USE |
61755-0008-01 |
— |
On market |
View → |
|
LIBTAYO cemiplimab-rwlc 50 mg/mL INJECTION
Regeneron · NDC 61755-0008-01 · J9119 · 1 VIAL, SINGLE-USE in 1 CARTON (61755-008-01) / 7 mL in 1 VIAL, SINGLE-USE |
61755-0008-01 |
— |
On market |
View → |
|
linvoseltamab 120 g/L SOLUTION
Regeneron · NDC 61755-0954-00 · 1 L in 1 BOTTLE (61755-954-00) |
61755-0954-00 |
— |
On market |
View → |
|
LYNOZYFIC linvoseltamab-gcpt 5 mg/2.5mL INJECTION, SOLUTION, CONCENTRATE
Regeneron · NDC 61755-0054-01 · J9601 · 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-054-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE (61755-054-00) |
61755-0054-01 |
— |
Discontinued |
View → |
|
LYNOZYFIC linvoseltamab-gcpt 200 mg/10mL INJECTION, SOLUTION, CONCENTRATE
Regeneron · NDC 61755-0056-01 · J9601 · 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-056-01) / 10 mL in 1 VIAL, SINGLE-DOSE (61755-056-00) |
61755-0056-01 |
— |
Discontinued |
View → |
|
maftivimab 50 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0961-00 · 1000 mL in 1 BOTTLE (61755-961-00) |
61755-0961-00 |
— |
On market |
View → |
|
maftivimab 100 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0964-00 · 1000 mL in 1 BOTTLE (61755-964-00) |
61755-0964-00 |
— |
On market |
View → |
|
odesivimab 100 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0965-00 · 1000 mL in 1 BOTTLE (61755-965-00) |
61755-0965-00 |
— |
On market |
View → |
|
odesivimab 50 mg/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0962-00 · 1000 mL in 1 BOTTLE (61755-962-00) |
61755-0962-00 |
— |
On market |
View → |
|
OTARMENI lunsotogene parvec-cwha 30000000000000 {GC}/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0062-99 · 1 CARTON in 1 BAG (61755-062-99) / 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-062-01) / 1 mL in 1 VIAL, SINGLE-DOSE (61755-062-00) |
61755-0062-99 |
— |
On market |
View → |
|
OTARMENI lunsotogene parvec-cwha 30000000000000 {GC}/mL INJECTION, SOLUTION
Regeneron · NDC 61755-0062-99 · 1 CARTON in 1 BAG (61755-062-99) / 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-062-01) / 1 mL in 1 VIAL, SINGLE-DOSE (61755-062-00) |
61755-0062-99 |
— |
On market |
View → |